< Back to scientific publications

Magazine 4.3

High Efficacy and Safety of Flat-Dose Ribavirin Plus Sofosbuvir/Daclatasvir in Genotype 3 Cirrhotic Patients.

Authors: Pellicelli A et al

Date: May 20

Scope of interest: infectious/hepatological




You may also be interested in:

Report/Poster of Convention/Congress Act

Poor Mobilizer” with myeloma or lymphoma. Experience of the”Tor Vergata”Polyclinic Stem Cell Collection Center

Authors: Fiorelli E., Lanti A., Ferraro A.S., D’Alessandro E., Chiru O.M., Del Proposto G., Cerrone P., De Angelis L., Guiducci G., Zinno F., Adorno G., Isacchi G., “ Plerixafor in association with G-CSF as a mobilization regimen in patients

Date: 2014

Scope of interest: Clinical pathology


Read details
Magazine 2,646

Pharmacoeconomics and ageing

Authors: Bustacchini S, Corsonello A, Onder G, Guffanti EE, Marchegiani F, Abbatecola AM, Lattanzio

Date: 2009

Scope of interest: pharmacology, ageing


Read details
Magazine 2.07

“Extracorporeal photochemotherapy in steroid refractory graft-versus-host disease: experience of Policlinico Tor Vergata”.

Authors: Fiorelli E, Lanti A, Docimo F, Adorno G

Date: 2014

Scope of interest: CLINICAL PATHOLOGY


Read details